Concepedia

Nicholas F. Kelland

NF

7

Publications

469

Citations

7

H-Index

2006

Active since

Affiliations

University of Cambridge(Current)

The University of Melbourne

Addenbrooke's Hospital

University of Edinburgh

The Royal Melbourne Hospital

Nicholas F. Kelland is an author at University of Cambridge specializing in medicine, cardiology, and cardiovascular pharmacology.

Top concepts

Publications per year

2006–2021

7

Publications

7

Profile of past and current clinical trials involving endothelin receptor antagonists: the novel "-sentan" class of drug.

Bruno Battistini, Nathalie Berthiaume, Nicholas F. Kelland et al. · PubMed · 2006 · 112 citations

, , +17

Deletion of Endothelial Cell Endothelin B Receptors Does Not Affect Blood Pressure or Sensitivity to Salt

Alan Bagnall, Nicholas F. Kelland, Fiona Gulliver-Sloan et al. · Hypertension · 2006 · 98 citations · Full text

Endothelial cell-specific ET<sub>B</sub> receptor knockout: autoradiographic and histological characterisation and crucial role in the clearance of endothelin-1This article is one of a selection of papers published in the two-part special issue entitled 20 Years of Endothelin Research.

Nicholas F. Kelland, Rhoda E. Kuc, Danielle L. McLean et al. · Canadian Journal of Physiology and Pharmacology · 2010 · 66 citations

Predictive value of impedance changes for real-time contact force measurements during catheter ablation of atrial arrhythmias in humans

Saurabh Kumar, Haris M. Haqqani, Martin Chan et al. · Heart Rhythm · 2013 · 62 citations

, , +13

Clinical trials of endothelin antagonists in heart failure: a question of dose?

Nicholas F. Kelland, David J. Webb · PubMed · 2006 · 56 citations

, , +19

Rows per page

1–5 of 7